Compositions and methods for the treatment of Pierce's disease
View Patent ↗Chimeric anti-microbial proteins, compositions, and methods for the therapeutic and prophylactic treatment of plant diseases caused by the bacterial pathogen Xylella fastidiosa are provided. The anti-microbial proteins of the invention generally comprise a surface recognition domain polypeptide, capable of binding to a bacterial membrane component, fused to a bacterial lysis domain polypeptide, capable of affecting lysis or rupture of the bacterial membrane, typically via a fused polypeptide linker. In particular, methods and compositions for the treatment or prevention of Pierce's disease of grapevines are provided. Methods for the generation of transgenic Vitus vinefera plants expressing xylem-secreted anti-microbial chimeras are also provided.
1. A chimeric anti-microbial protein comprising a surface recognition domain physically linked to an insect cecropin B, wherein the surface recognition domain is capable of binding to a component of the cell membrane of Xylella fastidiosa and is human neutrophil elastase or an active fragment thereof, and wherein the C-terminus of the surface recognition domain is physically linked to the N-terminus of insect cecropin B by a fused polypeptide linker of between 2 and 20 amino acid residues.
2. The chimeric anti-microbial protein of claim 1 , which anti-microbial protein has an amino acid sequence selected from the group consisting of SEQ ID NO: 4 and SEQ ID NO: 5.
3. An isolated nucleic acid molecule encoding a chimeric anti-microbial protein according to claim 2 .
4. An expression vector comprising the nucleic acid molecule of claim 3 .
5. A cell comprising the expression vector of claim 4 .
6. A method of producing a chimeric anti-microbial protein comprising:
(a) providing an expression vector according to claim 4 ,
(b) transforming or transfecting a suitable host cell with the expression vector, and
(c) expressing the chimeric anti-microbial protein encoded by the expression vector.
7. An isolated nucleic acid molecule encoding a chimeric anti-microbial protein according to claim 1 , the chimeric anti-microbial protein further containing a fused N-terminal xylem secretory leader.
8. An isolated nucleic acid molecule according to claim 7 , wherein the N-terminal xylem secretory leader is selected from the group consisting of SEQ ID NO: 6 and SEQ ID NO: 7.
9. An expression vector comprising the nucleic acid molecule of claim 8 .
10. A cell comprising the expression vector of claim 9 .
11. A Vitus vinifera cell comprising the expression vector of claim 9 .
12. A transgenic Vitus vinifera plant comprising the expression vector of claim 9 .
13. A method of treating Pierce's Disease in a Vitus vinifera plant infected with Xf, comprising introducing a chimeric anti-microbial protein according to claim 1 into the xylem of the infected Vitus vinifera plant.
14. A method of treating Pierce's Disease in a Vitus vinifera plant infected with Xf, comprising contacting Xf cells present in the infected plant with a chimeric anti-microbial protein according to claim 1 .
15. A method of treating Pierce's Disease in a Vitus vinifera plant infected with Xf, comprising spraying the Vitus vinifera plant with an adherent composition containing a chimeric anti-microbial protein according to claim 1 .
16. A method of preventing the development of Pierce's Disease in a Vitus vinifera plant, comprising spraying the Vitus vinifera plant with an adherent composition containing a chimeric anti-microbial protein according to claim 1 .
17. A method of inhibiting the spread of Pierce's Disease, comprising introducing a chimeric anti-microbial protein according to claim 1 into a glassy-winged sharpshooter insect vector of Xf.
18. The method according to claim 15 , wherein the chimeric anti-microbial protein is introduced into the glassy-winged sharpshooter insect by feeding the insect a composition containing the chimeric anti-microbial protein.